Methods: UA patients who treated with statin (n¼6) and without statin (n¼6) whole blood sample were detected miRNAs profile by using MiRNAs taqman low density array. 17 significant differential upregulated miRNAs were significant. MiRNAs targets were predicted by three bioinformatic tools. Putitive targets were clustered into different pathway and cell types by DAVID functional tool. GEO database Stable (n¼6) vs rupture plaque macrophage (n¼5); Early (n¼13) vs Advance carotid atherosclerotic plaque (n¼16) provided information were calculated by sam to figure out pathway in the rupture plaque. By using cytoscape to visualize the miRNAs regulated functional network.
Objectives: It has been previously demonstrated that hypoxia preconditioning (HP) potentiated the therapeutic effect of mesenchymal progenitor cells (MPC) on myocardial infarction. Given that exosomes, released from various cells, have been well recognized to play critical roles in cell-to-cell communication, we documented the exosomal miRNAs secreted from MPC with HP and examined their roles in cardiac function preservation after myocardial injury. Methods: For HP, MPC was subjected to repeated cycles of hypoxia (30 min) with intermittent reoxygenation (10 min) for three cycles. In vitro, CM was incubated in hypoxia for 24 hours to establish injury model. Concentrated conditioned medium (CdM) of MPC was extracted to be applied in the subsequent experiments, and exosome was isolated from CdM by differential centrifugation. GW4869, a special inhibitor to exosome, was used to interdict exosome release. The miRNAs transcriptome in exsome was analyzed by microarray and verified by quantified-PCR. Alternatively, ago-miR-210 or antago-miR-210 transfection was performed to up-or down-regulate intracellular miR-210 in MPC, respectively. In vivo, rats were subjected to left anterior descending (LAD) ligation followed by injection of either CdM-MPC , and added into CM medium. The co-location detection with an immunofluorescence in miR-210 and two special markers of exosome, CD81 and CD63, was performed to verify that miR-210 was secreted through exosome release. Afterwards, it was observed that miR-210 was internalized by CM via exosome-intake, resulting in a prominent rise in CM survival in a similar manner to Objectives: Atrial fibrillation (AF) is the most common sustained arrhythmia yet current pharmacological treatments are only moderately effective. Enhanced sarcoplasmic reticulum (SR) Ca 2+ leak via ryanodine receptor type-2 (RyR2) contributes to AF pathogenesis and preliminary data in atrial samples from paroxysmal AF (pAF) patients showed an upregulation of RyR2 proteins with no change in mRNA levels. This suggests that post-transcriptional regulation of RYR2 by microRNAs (miRNAs) may play a role in RyR2 dysregulation in pAF. Since bioinformatic analysis suggests that miR-106b and miR-93, members of the miR-106b-25 cluster, could target RYR2-3'UTR, we hypothesized that loss of the miR-106b-25 cluster may promote AF via enhanced RyR2-mediated SR Ca 2+ leak. Methods: RYR2-3'UTR luciferase reporter assay was performed in HEK293 cells. Telemetry ECG recordings, intracardiac electrophysiology (EP) studies, Ca 2+ imaging and immunocytochemistry (ICC) using isolated atrial myocytes, and Western blotting (WB) were performed in miR-106b-25 homozygous knockout (miR-106b-25 -/-) mice and wildtype (WT) littermates. Levels of mRNAs and mature miRNAs were measured using quantitative real-time (qRT) -PCR in both mice and atrial samples from pAF patients. Results: Luciferase reporter assay confirmed that miR-93 targets RYR2-3'UTR. WB and qRT-PCR revealed an upregulation of RyR2 proteins in miR-106b-25 -/-atria (n¼7) by 42% (P<0.01 vs. WT, n¼4) but unchanged mRNA levels. ICC showed that the subcellular localization of RyR2 remained unchanged in miR-106b-25 -/-atrial myocytes. Ca 2+ spark frequency (CaSF) normalized to SR load and total SR Ca 2+ leak were doubled in miR-106b-25 -/-atrial cells (both P<0.05 vs. WT; 3 animals/group). These increases in CaSF and SR Ca 2+ leak were normalized to WT levels when miR106b-25 -/-atrial myocytes were incubated with the RyR2-blocker K201 (1 mmol/L; both P<0.05 vs. untreated cells). Telemetry and EP studies showed that miR-106b-25 -/-mice exhibited more atrial ectopy (8AE2 events/hr, n¼8) than WT mice (1.0AE0.5 events/hr, n¼6, P<0.05) and were more susceptible to pacing-induced AF (75%, n¼8) than WT mice (12.5%, n¼8, P<0.05). RyR2-blocker K201 (10mg/kg, i.p.) reduced the incidence of pacing-induced AF in miR-106b-25 -/-mice (14.3%, n¼7, P<0.05 vs miR-106b-25 -/-). Finally, qRT-PCR demonstrated that the miR-106b-25 cluster is downregulated in atrial samples from pAF patients compared with patients in sinus rhythm (n¼5/group, P<0.05).
Conclusions: These results suggest that abnormal miR-106b-25 regulation of RYR2 expression is an important molecular mechanism involved in the proarrhythmic RyR2 dysregulation in pAF patients. miR-93 mimic may constitute a novel therapeutic strategy for pAF patients associated with RyR2 hyperactivity
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Mutational spectrum of the NKX2-5 gene in patients with atrial fibrillation Objectives: Atrial fibrillation (AF) is the most common form of sustained cardiac arrhythmia in humans and is responsible for substantial morbidity and mortality worldwide. Emerging evidence indicates that abnormal cardiovascular development is involved in the pathogenesis of AF. Methods: In this study, the coding exons and splice sites of the NKX2-5 gene, which encodes a homeodomain-containing transcription factor essential for cardiovascular genesis, were sequenced in 146 unrelated patients with lone AF as well as the available relatives of the mutation carriers. A total of 700 unrelated ethnically matched healthy individuals used as controls were genotyped. The disease-causing potential of the identified NKX2-5 variations was predicted by Mutation Taster and PolyPhen-2. The functional characteristics of the mutant NKX2-5 proteins were analyzed using a dual-luciferase reporter assay system. Results: As a result, two heterozygous NKX2-5 mutations, including a previously reported P.E21Q and a novel P.T180A mutation, were identified in two families with AF transmitted in an autosomal dominant pattern. The mutations co-segregated with AF in the families with complete penetrance. The detected substitutions, which altered the amino acids highly conserved evolutionarily across species, were absent in 700 control individuals and were both predicted to be causative. Functional analyses demonstrated JACC Vol 64/16/Suppl C j October 16-19, 2014 j GW-ICC Abstracts/Basic and Translational Medicine C59
